Vicore Pharma Holding AB(SE:VICO)
kr 10.72-0.26 (-2.37%)
SE:VICO
Vicore Pharma Holding AB financials statements
kr 10.72
At close:-0.26 (-2.37%)
Want to see SE:VICO full AI Analyst Report?
Vicore Pharma Holding AB (VICO) Income Statement
4 Followers
Vicore Pharma Holding AB Income Statement
Last quarter (Q3 2026), Vicore Pharma Holding AB's total revenue was kr594.00K, a decrease of 21.84% from the same quarter last year. In Q3, Vicore Pharma Holding AB's net income was kr-124.28M. See Vicore Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 3.82M | kr 109.35M | kr 0.00 | kr 0.00 | kr 0.00 | |
| kr 3.82M | kr 109.35M | kr -3.42M | kr -3.61M | kr -3.60M | |
| kr 458.26M | kr 303.54M | kr 321.51M | kr 287.49M | kr 293.42M | |
| Depreciation and Amortization | kr 0.00 | kr 2.24M | kr 3.42M | kr 3.61M | kr 3.60M |
| kr -477.41M | kr -166.64M | kr -317.47M | kr -286.20M | kr -289.82M | |
| kr -454.44M | kr -194.19M | kr -321.51M | kr -290.73M | kr -294.82M | |
| kr -23.03M | kr 25.30M | kr 10.18M | kr 1.92M | kr -1.92M | |
| kr -477.47M | kr -168.89M | kr -311.33M | kr -288.81M | kr -296.74M | |
| kr -477.47M | kr -168.63M | kr -310.94M | kr -288.42M | kr -296.48M | |
| Per Share Metrics | |||||
| Basic EPS | kr -1.99 | kr -0.75 | kr -3.22 | kr -3.99 | kr -4.25 |
| Diluted EPS | kr -1.99 | kr -0.75 | kr -3.22 | kr -3.99 | kr -4.25 |
| Weighted Average Shares Outstanding | 239.88M | 225.32M | 96.56M | 72.21M | 69.68M |
| Weighted Average Shares Outstanding (Diluted) | 239.88M | 225.32M | 96.56M | 72.21M | 69.68M |
Currency in SEK
